📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children. (2021)

First Author: Turkova A

Attributed to: Blood borne viruses funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2108793

PubMed Identifier: 34965338

Publication URI: http://europepmc.org/abstract/MED/34965338

Type: Journal Article/Review

Volume: 385

Parent Publication: The New England journal of medicine

Issue: 27

ISSN: 0028-4793